Next Article in Journal
Enhancing Therapeutic Efficacy of Donepezil, an Alzheimer’s Disease Drug, by Diplazium esculentum (Retz.) Sw. and Its Phytochemicals
Next Article in Special Issue
Eugenol Inhibits Neutrophils Myeloperoxidase In Vitro and Attenuates LPS-Induced Lung Inflammation in Mice
Previous Article in Journal
Shorter and Longer Antibiotic Durations for Respiratory Infections: To Fight Antimicrobial Resistance—A Retrospective Cross-Sectional Study in a Secondary Care Setting in the UK
Previous Article in Special Issue
Profiling the Phytochemicals of Orostachys margaritifolia: Biological Activities, LC-ESI/MS, and HPLC Analyses
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparative Antioxidant Potentials and Quantitative Phenolic Compounds Profiles among the Flowers and Leaves from Various Chrysanthemum morifolium Cultivars

1
Department of Bio-Industry Resources Engineering, Sejong University, Seoul 05006, Republic of Korea
2
Department of Plant Science and Technology, Chung-Ang University, Anseong 17546, Republic of Korea
3
Department of Plant Biotechnology, Sejong University, Seoul 05006, Republic of Korea
4
College of Korean Medicine, Gachon University, Seongnam 13120, Republic of Korea
5
Natural Product Institute of Science and Technology, Anseong 17546, Republic of Korea
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Pharmaceuticals 2024, 17(3), 340; https://doi.org/10.3390/ph17030340
Submission received: 8 February 2024 / Revised: 1 March 2024 / Accepted: 4 March 2024 / Published: 6 March 2024

Abstract

:
Chrysanthemum morifolium is a valuable plant that contains a wide range of phytochemical compounds and exhibits various biological activities. Ethanol extracts from both the leaves and flowers of 17 different cultivars of C. morifolium were tested for antioxidant activities using the 2,2-diphenyl-1-picrylhydrazyl and 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) assays and were quantitatively analyzed for 12 phenolic compounds using high-performance liquid chromatography with diode-array detection. We found that the ‘Ford’ and ‘Raina’ cultivars demonstrated strong antioxidant abilities and high phenolic compound contents compared to other cultivars, while the flowers of ‘Cielo’ and the leaves of ‘White Cap’ exhibited low antioxidant capacity in both assays. The ‘Cielo’ cultivar also displayed the lowest compound contents. Additionally, in most samples, 3,5-dicaffeoylquinic acid and 4,5-dicaffeoylquinic acid stood out as high-content compounds in the extracts. This study provides foundational knowledge that can be used for selecting appropriate C. morifolium cultivars for further research. Moreover, the ‘Ford’ and ‘Raina’ cultivars, containing high amounts of bioactive compounds and showing superior antioxidant ability, could be applied to produce health-beneficial products.

1. Introduction

The widespread recognition of the oxidation reaction’s significance to both the human body and food has led to an understanding that oxidative metabolism is vital for cell survival. However, a consequence of this reliance is the generation of free radicals and other reactive oxygen species, resulting in oxidative changes [1,2]. Over the past decade, diseases or disorders associated with oxidative stress—including metabolic, neurodegenerative, cardiovascular, and mitochondrial diseases and cancer—have garnered considerable attention [3,4,5]. Numerous studies have explored the underlying triggers, seeking to elucidate the mechanisms of action of free radicals and identify effective substances that prevent or reverse oxidative damage [6,7].
Antioxidants demonstrate high efficacies in regulating the production of free radicals, preventing their undesirable effects, and supporting the body’s antioxidant and detoxifying mechanisms [8,9,10,11]. They can naturally occur in plants, animals, and microorganisms or may be synthesized through chemical means. Higher plants and their component compounds serve as abundant sources of natural antioxidants, such as tocopherols and polyphenols, which are prevalent in spices, herbs, fruits, vegetables, cereals, grains, seeds, teas, and oils [12,13,14]. The isolation of naturally occurring antioxidants as pure compounds from their source materials opens possibilities for their use in nutraceutical and pharmaceutical applications [15,16]. Recently, numerous methods have been employed to evaluate the efficacy of natural antioxidants. These methods encompass assays such as DPPH (2,2-diphenyl-1-picrylhydrazyl) and ABTS+ (2,2-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid), the ferric reducing antioxidant power, the β-carotene/linoleic acid, the Rancimat method, and the inhibition of low-density lipoprotein oxidation. Notably, among these methods, DPPH and ABTS are two popular approaches [17].
Phenolic compounds—widely present in medicinal plants, spices, vegetables, fruits, grains, pulses, and seeds—encompass thousands of molecules with diverse chemical structures. They constitute a significant category of natural antioxidants with potential positive impacts on human health [18]. These compounds have been reported to exhibit various biological activities, including antioxidant activity [19,20,21]. Recently, phenolics have gained recognition as potent antioxidants in vitro, surpassing the antioxidant potencies of vitamins E and C, as well as carotenoids [22,23,24,25]. The inverse relationship between fruit and vegetable intake and the risks of cardiovascular and neurodegenerative diseases, cancer, diabetes, and osteoporosis has been partially attributed to phenolics [26,27,28,29,30]. These benefits have earned the attention of scientists, food manufacturers, and consumers, and this growing interest aligns with the evolving trend toward functional foods designed to offer specific health benefits [31,32,33].
Chrysanthemum, a genus in the Asteraceae family, comprises approximately 40 species and is extensively distributed in Asia, notably in Mongolia, China, Japan, and eastern Europe [34]. Though it is predominantly cultivated worldwide for ornamental purposes today [35], Chrysanthemum morifolium Ramat is recognized as one of the most economically significant ‘food and drug dual-use’ plants globally and has been traditionally consumed for health and disease prevention [36,37,38]. As people’s living standards continue to rise, and health awareness increases, dietary herbal medicines like C. morifolium are gaining greater importance in daily life [39]. Notably, C. morifolium is renowned for its traditional efficacies, including scattering cold, brightening eyes, reducing heat, and cleansing toxins, making it applicable for conditions such as swelling and pain of the eyes, common colds with the wind–heat pattern, and dim-sightedness [40]. Additionally, numerous modern pharmacological studies have reported diverse key bioactive compounds in C. morifolium, such as phenolics (isochlorogenic acid C, chlorogenic acid, and cryptochlorogenic acid), caffeoylquinic acids, flavonoids (luteolin, apigenin-7-glucoside, and apigenin), and carotenoids, steroids, and terpenoids [41,42]. These components exhibit various activities, displaying anticancer, antimutagenic, anti-inflammatory, anti-human immunodeficiency viruses, antioxidative, neuroprotective, antidiabetic, antihypertensive, and aldose reductase inhibition effects [43,44,45,46].
In this study, the compounds from the flowers and leaves of 17 different C. morifolium cultivars were extracted and evaluated for their antioxidant ability using DPPH and ABTS+ assays. Subsequently, these samples were analyzed for 12 phenolic compounds using high-performance liquid chromatography with diode-array detection (HPLC-DAD).

2. Results

2.1. Antioxidant Activity

The antioxidant activities of extracts from the flowers and leaves of different C. morifolium cultivars were evaluated based on their IC50 values (Table 1 and Table 2).
The higher the IC50, the lower the antioxidant ability, and vice versa. In general, the IC50 values of the flower samples ranged from 1.26 to 6.21 mg/mL in the DPPH assay and 1.14 to 5.65 mg/mL in the ABTS+ assay, while the IC50 values of the leaf samples ranged from 2.10 to 20.86 mg/mL in the DPPH assay and 1.82 to 11.48 mg/mL in the ABTS+ assay. In contrast, the control sample (ascorbic acid) had an IC50 of 0.10 mg/mL, indicating that the antioxidant activity of all samples was more than 10 times lower than that of ascorbic acid. Moreover, in the same cultivar, most flower samples exhibited stronger antioxidant ability than leaf samples. Only in the ‘Yes Holic’ cultivar did leaf samples show a higher antioxidant ability, and this was only true in the DPPH assay; however, the differences between the two IC50 values were not remarkable.
According to the DPPH results (Table 1), among the flower samples, the strongest antioxidant activity was found in S3 (‘Powaru’, 1.26 mg/mL), followed by S17 (‘Ford’, 1.27 mg/mL) and then S7 (‘Raina’, 1.35 mg/mL), while the weakest antioxidant activity was found in S13 (‘Cielo’, 6.21 mg/mL). Conversely, the highest antioxidant activity among leaf samples was found in S32 (‘Geumsu’, 2.10 mg/mL), followed by S24 (‘Raina’, 2.18 mg/mL) and S34 (‘Ford’, 2.65 mg/mL), with the lowest antioxidant activity observed in S26 (‘White Cap’, 20.86 mg/mL).
In the ABTS+ results (Table 2), S3 (‘Powaru’, 1.14 mg/mL) again demonstrated the highest antioxidant ability among flower samples, followed by S15 (‘Geumsu’, 1.33 mg/mL), S17 (‘Ford’, 1.38 mg/mL), and S7 (‘Raina’, 1.71 mg/mL), while the lowest antioxidant ability was found in S13 (‘Cielo’, 5.65 mg/mL). Similarly, among leaf samples, S32 (‘Geumsu’, 1.82 mg/mL) exhibited the strongest antioxidant ability, followed by S24 (‘Raina’, 1.85 mg/mL), S23 (‘Corsage’, 2.46 mg/mL), and S34 (‘Ford’, 2.59 mg/mL), with the weakest antioxidant ability observed in S26 (‘White Cap’, 11.48 mg/mL).
In summary, among the flower and leaf samples, S3 (‘Powaru’) and S32 (‘Geumsu’) exhibited the highest antioxidant activity, while S13 (‘Cielo’) and S26 (‘White Cap’) demonstrated the lowest. Additionally, among the 17 cultivars, ‘Ford’ and ‘Raina’ stood out as cultivars with high antioxidant levels.

2.2. HPLC Analysis

Thirty-four extract samples from C. morifolium flowers and leaves were analyzed to quantify the content of 12 phenolic compounds using the HPLC-DAD method.
All compounds were well separated, with retention times spanning from 13.04 to 41.44 min. Additionally, calibration curves for each compound were constructed, and their correlation factors were all 0.9992 or higher (Table 3), demonstrating the excellent linearity of the employed method. Based on these calibration equations, the content of each compound in each sample was determined (Table 4 and Table 5). The chromatograms of standard compounds and the flower and leaf samples are shown in Figure 1, Figure 2 and Figure 3, respectively.
Overall, only four compounds, namely, 3-O-caffeoylquinic acid (1), luteolin 7-O-glucoside (4), apigenin 7-O-glucoside (5), and 4,5-dicaffeoylquinic acid (8), were consistently present in all samples. In contrast, schaftoside (2) and isoschaftoside (3) were detected in only some samples and in relatively low amounts. Luteolin 7-O-glucoside (4), 3,5-dicaffeoylquinic acid (6), and 4,5-dicaffeoylquinic acid (8) contents were generally high in flower samples, whereas most leaf samples showed high levels of 3,5-dicaffeoylquinic acid (6) and 4,5-dicaffeoylquinic acid (8).
Showing consistency with the antioxidant activity results, the majority of flower samples contained higher concentrations of the surveyed compounds than the leaf samples. Nevertheless, exceptions were noted in the ‘Argus’ and ‘Geumsu’ cultivars, where leaf samples exhibited a slightly higher content.
Concerning the total content of the 12 compounds in the flower extracts, S17 (‘Ford’, 200.68 mg/g extract) exhibited the highest content, followed by S7 (‘Raina’, 149.82 mg/g extract) and then S3 (‘Powaru’, 120.75 mg/g extract), with S13 (‘Cielo’, 26.32 mg/g extract) displaying the lowest content. However, in leaf extracts, S32 (‘Geumsu’, 81.73 mg/g extract) exhibited the highest content, followed by S24 (‘Raina’, 64.95 mg/g extract), S18 (‘Argus’, 41.16 mg/g extract), S20 (‘Powaru’, 38.94 mg/g extract), and S34 (‘Ford’, 35.69 mg/g extract) while the lowest content was observed in S26 (‘White Cap’, 5.52 mg/g extract) and S30 (‘Cielo’, 4.75 mg/g extract).
Taken together, S17 (‘Ford’) and S32 (‘Geumsu’) exhibited the highest total compound contents in flowers and leaves, respectively, whereas flower sample S13 (‘Cielo’) and leaf samples S26 (‘White Cap’) and S30 (‘Cielo’) displayed the lowest. The ‘Ford’ and ‘Raina’ cultivars generally showed the highest total compound contents among the cultivars, while ‘Cielo’ showed the lowest.

3. Discussion

Phenolic compounds, comprising flavonoids and phenolic acids, are recognized as contributors to the antioxidant capacities of fruits. Additionally, fruits containing higher phenolic contents typically exhibit stronger antioxidant capacities [47,48]. This trend was also observed in this study, where the levels of 12 phenolic compounds in the C. morifolium extracts were closely related to their antioxidant capacity. Specifically, flower extract samples S17, S7, and S3, which contained high compound levels, exhibited stronger antioxidant capacities than other samples. Conversely, S13, with a low compound level, showed the weakest antioxidant ability among the flower samples. A similar trend was observed in leaf samples, where high-compound content samples S32, S24, and S34 demonstrated strong antioxidant activity, while S26, with a low compound content, exhibited weak antioxidant capacity.
In contrast, some samples exhibited high levels of phenolic compounds, yet their antioxidant activity was notably low. It is crucial to note that this study exclusively focused on 12 phenolic compounds. Many other compounds present in the samples were not evaluated. Previous studies have identified a wide range of bioactive compounds in C. morifolium, including quercetin, isorhamnetin 3-O-glucoside, eriodictyol, pyracanthoside, apigetrin, acacipetalin, diosmetin, spinacetin, axillarin, bonanzin, cirsiliol, chrysosplenol D, artemetin, quercitrin, acacetin 7-O-glucoside, apigenin 7-O-glucoside, and luteolin 7-O-glucoside [49,50,51]. Therefore, the results of this study only partially characterize the samples, and further research is necessary to conclusively identify which compounds significantly influence the antioxidant capacity of C. morifolium extracts. Additionally, it is important to note that many other compounds, besides phenolic compounds, contribute to the biological activities of C. morifolium, such as carotenoids, steroids, and terpenoids. Therefore, the presence of phenolic compounds contributes to the antioxidant ability, but it cannot be said that the antioxidant ability as well as biological processes are solely determined by phenolic compounds.
On the other hand, while the antioxidant ability of the flower samples was considerably higher than that of the leaf samples, it is easier to cultivate and obtain a high amount of leaf samples rather than flower samples. Furthermore, in contrast to leaf samples, extracting flower samples is more prone to obtaining undesirable substances such as oils. Consequently, it is essential to carefully consider both antioxidant abilities and other relevant conditions when choosing the appropriate samples.
In our previous study, we quantified the antioxidant capacity as well as the content of phenolic compounds (including the 12 compounds this study focused on) in three different Chrysanthemum species from various regions in South Korea [52]. The IC50 values of the extracts in that study ranged from 5.8 to 17.4 mg/mL in a DPPH assay and 2.7 to 9.4 mg/mL in an ABTS+ assay, and the total content of phenolic compounds ranged from 7.87 to 95.13 mg/g extract. In the current study, the flower extracts exhibited IC50 values ranging from 1.14 to 6.21 mg/mL in the DPPH assay and 1.14 to 5.65 mg/mL in an ABTS+ assay, and the total content of phenolic compounds ranged from 26.32 to 200.68 mg/g extract. Thus, both the antioxidant capacity and the bioactive compound levels in the flower samples from the 17 cultivars in this study surpassed those observed in the previous study despite similar extraction procedures.
Another study reported that C. zawadskii var. lucidum flowers, containing high levels of 3-O-caffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid, and acacetin 7-O-rutinoside, exhibited skin-whitening activity by inhibiting melanin production in α-melanocyte-stimulating hormone-induced B16F10 cells [53,54,55]. The study also confirmed their antimicrobial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans. Therefore, the samples in this study with high concentrations of phenolic compounds are also expected to demonstrate both skin-whitening and antimicrobial activities.
Furthermore, most previous studies have concentrated on investigating compounds and biological activities in the flowers of Chrysanthemum species rather than the leaves. Therefore, our study not only demonstrates the differences in biological properties between the flowers and leaves of Chrysanthemum species but also fills the gap in studies on the leaves of Chrysanthemum species. Although the biological activity of the leaves is not as potent as that of the flowers, it is evident that C. morifolium leaves still exhibit considerable biological activity that warrants further investigation.

4. Materials and Methods

4.1. Plant Materials

Seventeen cultivars of C. morifolium (Figure 4) were grown by Prof. Jinhee Lim, Sejong University, Republic of Korea, in May 2023.
Seedlings were sown in May 2023, and the leaves and flowers were freshly harvested in September 2023 (~16 weeks old), dried, and cut into small pieces before extraction. All specimens (S1–S34) were deposited at the herbarium of the Department of Bio-Industry Resources Engineering, Sejong University, Seoul, Republic of Korea.

4.2. Instruments and Reagents

The HPLC analysis was conducted using an Agilent 1260 Infinity II Quat Pump (Santa Clara, CA, USA) and a DAD. The configuration comprised a pump and an auto-sampler, integrated with a YMC Pack Pro C18 column (4.6 × 250 mm, 5 µm). The HPLC-grade solvents, including water, acetonitrile, and methanol (MeOH), were procured from J. T. Baker (Philipsburg, PA, USA). In addition, acetic acid was acquired from Samchun Chemicals (Pyeongtaek, Republic of Korea). In the context of the assays, both an Epoch microplate spectrophotometer from BioTek (Winooski, VT, USA) and a microplate reader were utilized.
To determine radical scavenging activity, DPPH and ABTS+ assays were performed using potassium persulfate obtained from Sigma (Burlington, MA, USA). Additionally, a collection of 12 phenolic compounds (Figure 5) was sourced from the Natural Product Institute of Science and Technology (www.nist.re.kr (accessed on 7 July 2023)), Anseong, Republic of Korea. These were assigned numbers from 1 to 12 for convenience throughout the paper and included 3-O-caffeoylquinic acid (1), schaftoside (2), isoschaftoside (3), luteolin 7-O-glucoside (4), apigenin 7-O-glucoside (5), 3,5-dicaffeoylquinic acid (6), 3,4-dicaffeoylquinic acid (7), 4,5-dicaffeoylquinic acid (8), acacetin 7-O-rutinoside (9), luteolin (10), apigenin (11), and acacetin (12).

4.3. Sample Extraction and Preparation

For each C. morifolium cultivar, 5 g each of dried flower and leaf tissue was subjected to extraction using ethanol in a reflux extractor for 3 h. This extraction process was replicated three times. Following dehydration in a rotary evaporator, the extracts were gathered. For each extract, 20 mg was precisely measured and diluted in 1 mL of MeOH or 1 mL of distilled water to form stock solutions for the DPPH and ABTS+ assays, respectively. After filtering through a 0.45 µm membrane filter, sequential dilutions were performed on the stock solutions. To prepare for the HPLC analysis, each extract was dissolved in MeOH, appropriately diluted, and formulated. After dissolution by ultra-sonication, the solution was filtered using a 0.45 μm polyvinylidene fluoride (PVDF) membrane filter to prepare the test solution. For each of the 12 standard compounds, 4 mg was precisely weighed and dissolved in 1 mL of MeOH to create a 4000 ppm stock solution. After complete dissolution by ultra-sonication, the solutions were filtered using a 0.45 μm PVDF membrane filter.

4.4. DPPH Radical Scavenging Activity

The DPPH radical scavenging assays were performed using 0.2 mM DPPH working solutions created by diluting the original DPPH stock solution with MeOH. Next, 10 µL of each test solution was combined with 200 µL of the DPPH working solution in respective wells of a 96-well plate. This was repeated three times to ensure accuracy. Then, the solutions were mixed thoroughly using a microplate shaker and incubated in darkness for 30 min. Subsequently, the solution’s absorbance was measured at a wavelength of 514 nm, and the DPPH radical scavenging rate was calculated. The calculated rates were used to construct activity concentration curves for determining the IC50 values.

4.5. ABTS+ Radical Scavenging Activity

The ABTS+ radical scavenging assay was performed by diluting the ABTS+ stock solution in water to create the ABTS+ working solutions. Subsequently, 10 µL of test solution was combined with 200 µL of the ABTS+ working solution in a 96-well plate, with the reaction being replicated three times. The solutions were mixed thoroughly on a microplate shaker and incubated for 30 min in the dark before the absorbance was measured at 734 nm. The ABTS+ radical scavenging rates were calculated and used to construct curves for IC50 determination.

4.6. HPLC Conditions

A quantitative chemical analysis of the extracts was conducted using a reverse-phase HPLC system, employing a YMC Pack-Pro C18 column (25 cm × 4.6 mm, 5 μm), and a gradient elution. The mobile phase was composed of 0.25% acetic acid in water (A) and acetonitrile (B), and the elution conditions were 10% B from 0 min to 5 min, increasing to 20% B at 10 min, 27% B at 30 min, 40% B at 35 min, and 100% B at 40 min, which was maintained until 60 min. The column temperature was retained at 30 °C, with an injection volume of 10 μL, a flow rate of 1.0 mL/min, and wavelength monitoring set to 356 nm.

4.7. Calibration Curve

The calibration curve for the HPLC-DAD analysis was generated by plotting the concentrations of the 12 compounds’ standard solutions against their corresponding peak areas. To evaluate the linearity of the curves, we used the correlation coefficient (r2), and then the calibration curves were used to compute the concentrations of the standard compounds in the samples. The calibration equations were established using the mean peak area value (Y) ± standard deviation (n = 3) and concentration (X, µg/mL).

5. Conclusions

The antioxidant activities of the flower and leaf extracts from 17 cultivars of C. morifolium were evaluated using DPPH and ABTS+ assays. Additionally, the presence of 12 phenolic compounds in the extract samples was detected and quantified through HPLC-DAD analysis. The results revealed that 2 out of the 17 cultivars (‘Ford’ and ‘Raina’) exhibited particularly strong antioxidant activities and particularly high compound contents. Moreover, 3,5-dicaffeoylquinic acid (6) and 4,5-dicaffeoylquinic acid (8) exhibited high contents relative to the other compounds in most of the samples. This study contributes valuable insights into the compounds that various cultivars of C. morifolium can offer and also adds to research on other Chrysanthemum species. Given the high content of bioactive compounds and the remarkable antioxidant capacity observed in the ‘Ford’ and ‘Raina’ cultivars, they can be considered potential sources of natural materials applicable in diverse industries, including pharmaceuticals, cosmetics, and food.

Author Contributions

Antioxidant activity analyses, T.T.M.D. and T.K.N.; HPLC/DAD analysis, G.H.T.; experimental design and conception, K.S.K.; experimental design and resources, J.H.L.; supervision, writing—review, and editing, S.L. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the Cooperative Research Program for Agriculture Science & Technology Development (Project No. RS-2022-RD010014) of the Rural Development Administration, Republic of Korea.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Acknowledgments

We thank the Natural Product Institute of Science and Technology for their donation of compounds 112.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Antolovich, M.; Prenzler, P.D.; Patsalides, E.; McDonald, S.; Robards, K. Methods for testing antioxidant activity. Analyst 2002, 127, 183–198. [Google Scholar] [CrossRef]
  2. Martins, N.; Barros, L.; Ferreira, I.C. In vivo antioxidant activity of phenolic compounds: Facts and gaps. Trends Food Sci. Technol. 2016, 48, 1–12. [Google Scholar] [CrossRef]
  3. Chaturvedi, R.K.; Beal, M.F. Mitochondrial diseases of the brain. Free Radic. Biol. Med. 2013, 63, 1–29. [Google Scholar] [CrossRef]
  4. Halliwell, B. Free radicals and antioxidants: Updating a personal view. Nutr. Rev. 2012, 70, 257–265. [Google Scholar] [CrossRef]
  5. Singh, R.P.; Sharad, S.; Kapur, S. Free radicals and oxidative stress in neurodegenerative diseases: Relevance of dietary antioxidants. J. Indian Acad. Clin. Med. 2004, 5, 218–225. [Google Scholar]
  6. Espín, J.C.; García-Conesa, M.T.; Tomás-Barberán, F.A. Nutraceuticals: Facts and fiction. Phytochemistry 2007, 68, 2986–3008. [Google Scholar] [CrossRef]
  7. Fernandez-Panchon, M.S.; Villano, D.; Troncoso, A.M.; Garcia-Parrilla, M.C. Antioxidant activity of phenolic compounds: From in vitro results to in vivo evidence. Crit. Rev. Food Sci. Nutr. 2008, 48, 649–671. [Google Scholar] [CrossRef]
  8. Holst, B.; Williamson, G. Nutrients and phytochemicals: From bioavailability to bioefficacy beyond antioxidants. Curr. Opin. Biotechnol. 2008, 19, 73–82. [Google Scholar] [CrossRef] [PubMed]
  9. Kapravelou, G.; Martínez, R.; Andrade, A.M.; Lopez Chaves, C.; López-Jurado, M.; Aranda, P.; Arrebola, F.; Cañizares, F.J.; Galisteo, M.; Porres, J.M. Improvement of the antioxidant and hypolipidaemic effects of cowpea flours (Vigna unguiculata) by fermentation: Results of in vitro and in vivo experiments. J. Sci. Food Agric. 2015, 95, 1207–1216. [Google Scholar] [CrossRef] [PubMed]
  10. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44–84. [Google Scholar] [CrossRef] [PubMed]
  11. Yeh, C.T.; Yen, G.C. Modulation of hepatic phase II phenol sulfotransferase and antioxidant status by phenolic acids in rats. J. Nutr. Biochem. 2006, 17, 561–569. [Google Scholar] [CrossRef]
  12. Amarowicz, R.; Karamać, M.; Shahidi, F. Synergistic activity of capelin protein hydrolysates with synthetic antioxidants in a model system. J. Food Lipids 1999, 6, 271–275. [Google Scholar] [CrossRef]
  13. Athukorala, Y.; Lee, K.W.; Song, C.; Ahn, C.B.; Shin, T.S.; Cha, Y.J.; Shahidi, F.; Jeon, Y.J. Potential antioxidant activity of marine red alga Grateloupia filicina extracts. J. Food Lipids 2003, 10, 251–265. [Google Scholar] [CrossRef]
  14. Shahidi, F.; Amarowicz, R. Antioxidant activity of protein hydrolyzates from aquatic species. J. Am. Oil Chem. Soc. 1996, 73, 1197–1199. [Google Scholar] [CrossRef]
  15. Shahidi, F.; Zhong, Y. Measurement of antioxidant activity. J. Funct. Foods 2015, 18, 757–781. [Google Scholar] [CrossRef]
  16. Munteanu, I.G.; Apetrei, C. Analytical methods used in determining antioxidant activity: A review. Int. J. Mol. Sci. 2021, 22, 3380. [Google Scholar] [CrossRef] [PubMed]
  17. Moon, J.K.; Shibamoto, T. Antioxidant assays for plant and food components. J. Agric. Food Chem. 2009, 57, 1655–1666. [Google Scholar] [CrossRef] [PubMed]
  18. Stratil, P.; Klejdus, B.; Kubáň, V. Determination of phenolic compounds and their antioxidant activity in fruits and cereals. Talanta 2007, 71, 1741–1751. [Google Scholar] [CrossRef]
  19. Kähkönen, M.P.; Hopia, A.I.; Vuorela, H.J.; Rauha, J.P.; Pihlaja, K.; Kujala, T.S.; Heinonen, M. Antioxidant activity of plant extracts containing phenolic compounds. J. Agric. Food Chem. 1999, 47, 3954–3962. [Google Scholar] [CrossRef] [PubMed]
  20. Wojdyło, A.; Oszmiański, J.; Czemerys, R. Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem. 2007, 105, 940–949. [Google Scholar] [CrossRef]
  21. Choi, J.; Lee, H.-D.; Cho, H.; Lee, C.-D.; Tran, G.H.; Kim, H.; Moon, S.K.; Lee, S. Antioxidative phenolic compounds from the aerial parts of Cyperus exaltatus var. iwasakii and their HPLC analysis. Appl. Biol. Chem. 2023, 66, 61. [Google Scholar] [CrossRef]
  22. Frankel, E.N.; Waterhouse, A.L.; Kinsella, J.E. Inhibition of human LDL oxidation by resveratrol. Lancet 1993, 341, 1103–1104. [Google Scholar] [CrossRef]
  23. Frankel, E.N.; Waterhouse, A.L.; Teissedre, P.L. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J. Agric. Food Chem. 1995, 43, 890–894. [Google Scholar] [CrossRef]
  24. Sato, M.; Ramarathnam, N.; Suzuki, Y.; Ohkubo, T.; Takeuchi, M.; Ochi, H. Varietal differences in the phenolic content and superoxide radical scavenging potential of wines from different sources. J. Agric. Food Chem. 1996, 44, 37–41. [Google Scholar] [CrossRef]
  25. Villaño, D.; Fernández-Pachón, M.S.; Troncoso, A.M.; García-Parrilla, M.C. Comparison of antioxidant activity of wine phenolic compounds and metabolites in vitro. Anal. Chim. Acta 2005, 538, 391–398. [Google Scholar] [CrossRef]
  26. Scalbert, A.; Manach, C.; Morand, C.; Rémésy, C.; Jiménez, L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 2005, 45, 287–306. [Google Scholar] [CrossRef] [PubMed]
  27. Criqui, M.H.; Ringel, B.L. Does diet or alcohol explain the French paradox? Lancet 1994, 344, 1719–1723. [Google Scholar] [CrossRef] [PubMed]
  28. Renaud, S.D.; de Lorgeril, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339, 1523–1526. [Google Scholar] [CrossRef] [PubMed]
  29. Hollman, P.C.H.; Katan, M.B. Dietary flavonoids: Intake, health effects and bioavailability. Food Chem. Toxicol. 1999, 37, 937–942. [Google Scholar] [CrossRef] [PubMed]
  30. Steinmetz, K.A.; Potter, J.D. Vegetables, fruit, and cancer prevention: A review. J. Am. Diet. Assoc. 1996, 96, 1027–1039. [Google Scholar] [CrossRef] [PubMed]
  31. Velioglu, Y.; Mazza, G.; Gao, L.; Oomah, B.D. Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products. J. Agric. Food Chem. 1998, 46, 4113–4117. [Google Scholar] [CrossRef]
  32. Robards, K.; Prenzler, P.D.; Tucker, G.; Swatsitang, P.; Glover, W. Phenolic compounds and their role in oxidative processes in fruits. Food Chem. 1999, 66, 401–436. [Google Scholar] [CrossRef]
  33. Karakaya, S.; El, S.N.; Taş, A.A. Antioxidant activity of some foods containing phenolic compounds. Int. J. Food Sci. Nutr. 2001, 52, 501–508. [Google Scholar] [CrossRef] [PubMed]
  34. Youssef, F.S.; Eid, S.Y.; Alshammari, E.; Ashour, M.L.; Wink, M.; El-Readi, M.Z. Chrysanthemum indicum and Chrysanthemum morifolium: Chemical composition of their essential oils and their potential use as natural preservatives with antimicrobial and antioxidant activities. Foods 2020, 9, 1460. [Google Scholar] [CrossRef]
  35. Mabberley, D.J. Mabberley’s Plant-Book: A Portable Dictionary of Plants, Their Classification and Uses, 4th ed.; Cambridge University Press: Cambridge, UK, 2017. [Google Scholar]
  36. Boase, M.R.; Miller, R.; Deroles, S.C. Chrysanthemum systematics, genetics, and breeding. Plant Breed. Rev. 1997, 14, 321–361. [Google Scholar]
  37. Guo, Q.S.; Wang, T.; Cheng, L.T.; Wen, J.J.; Wang, T.Y.; Liang, Y.N. Study on quality of flavone in various cultivars of Chrysanthemum morifolium for medicine. China J. Chin. Mater. Medica 2008, 33, 756–759. [Google Scholar]
  38. Li, P.; Zhang, F.; Chen, S.; Jiang, J.; Wang, H.; Su, J.; Fang, W.; Guan, Z.; Chen, F. Genetic diversity, population structure and association analysis in cut chrysanthemum (Chrysanthemum morifolium Ramat.). Mol. Genet. Genom. 2016, 291, 1117–1125. [Google Scholar] [CrossRef]
  39. Ouyang, H.; Fan, Y.; Wei, S.; Chang, Y.; He, J. Study on the chemical profile of Chrysanthemum (Chrysanthemum morifolium) and the evaluation of the similarities and differences between different cultivars. Chem. Biodivers. 2022, 19, e202200252. [Google Scholar] [CrossRef]
  40. Chinese Pharmacopoeia Commission. The Pharmacopoeia of the People’s Republic of China 1; China Medical Science Press: Beijing, China, 2015; p. 232. (In Chinese)
  41. Chen, S.; Liu, J.; Dong, G.; Zhang, X.; Liu, Y.; Sun, W.; Liu, A. Flavonoids and caffeoylquinic acids in Chrysanthemum morifolium Ramat flowers: A potentially rich source of bioactive compounds. Food Chem. 2021, 344, 128733. [Google Scholar] [CrossRef]
  42. Zhan, J.; He, F.; Cai, H.; Wu, M.; Xiao, Y.; Xiang, F.; Yang, Y.; Ye, C.; Wang, S.; Li, S. Composition and antifungal mechanism of essential oil from Chrysanthemum morifolium cv. Fubaiju. J. Funct. Foods 2021, 87, 104746. [Google Scholar] [CrossRef]
  43. Xie, Z.; Zhang, Q.; Zhu, L.; Han, G. Research progress on chemical constituents and pharmacological activities of Chrysanthemum morifolium. J. Henan Univ. (Med. Sci.) 2015, 34, 290–300. [Google Scholar]
  44. Xue, M.; Shi, H.; Zhang, J.; Liu, Q.Q.; Guan, J.; Zhang, J.Y.; Ma, Q. Stability and degradation of caffeoylquinic acids under different storage conditions studied by high-performance liquid chromatography with photo diode array detection and high-performance liquid chromatography with electrospray ionization collision-induced dissociation tandem mass spectrometry. Molecules 2016, 21, 948. [Google Scholar] [PubMed]
  45. Yang, W.; Su, Y.; Dong, G.; Qian, G.; Shi, Y.; Mi, Y.; Zhang, Y.; Xue, J.; Du, W.; Shi, T.; et al. Liquid chromatography–mass spectrometry-based metabolomics analysis of flavonoids and anthraquinones in Fagopyrum tataricum L. Gaertn. (tartary buckwheat) seeds to trace morphological variations. Food Chem. 2020, 331, 127354. [Google Scholar] [CrossRef] [PubMed]
  46. Zhong, A.J.; Jiang, Z.; Zheng, X.; Ning, L.I.; Pharmacy, D.O. Research progress on chemical constituents and pharmacological activities of Chrysanthemi Flos. Drugs Clin. 2014, 29, 824–830. [Google Scholar]
  47. Rice-Evans, C.A.; Miller, N.J. Antioxidant activities of flavonoids as bioactive components of food. Biochem. Soc. Trans. 1996, 24, 790–795. [Google Scholar] [CrossRef] [PubMed]
  48. Fang, Z.; Zhang, Y.; Lü, Y.; Ma, G.; Chen, J.; Liu, D.; Ye, X. Phenolic compounds and antioxidant capacities of bayberry juices. Food Chem. 2009, 113, 884–888. [Google Scholar] [CrossRef]
  49. Hu, J.; Ma, W.; Li, N.; Wang, K.J. Antioxidant and anti-inflammatory flavonoids from the flowers of Chuju, a medical cultivar of Chrysanthemum morifolim Ramat. J. Mex. Chem. Soc. 2017, 61, 282–289. [Google Scholar] [CrossRef]
  50. Chung, H.S. Phenolic compounds with antioxidant activity on DPPH free radical scavenging and inhibition of xanthine/xanthine oxidase from the flowers of Chrysanthemum morifolium. Prev. Nutr. Food Sci. 2006, 11, 198–203. [Google Scholar] [CrossRef]
  51. Han, A.R.; Kim, H.Y.; So, Y.; Nam, B.; Lee, I.S.; Nam, J.W.; Jo, Y.D.; Kim, S.H.; Kim, J.B.; Kang, S.Y.; et al. Quantification of antioxidant phenolic compounds in a new Chrysanthemum cultivar by high-performance liquid chromatography with diode array detection and electrospray ionization mass spectrometry. Int. J. Anal. Chem. 2017, 2017, 1254721. [Google Scholar] [CrossRef]
  52. Doan, T.M.T.; Uy, N.P.; Tran, G.H.; Lee, S.; Lim, J.H. Antioxidant activity of the Chrysanthemum family and quantitative analysis of phenolic compounds by HPLC/UV. J. Biol. Regul. Homeost. Agents 2024, 38, 137–148. [Google Scholar]
  53. So, J.; Lee, H.D.; Kim, J.H.; Lee, S.; Lim, J.H. Antioxidant, antimicrobial, and skin-whitening effects and quantitative analysis of phenolic compounds in Korean wild Chrysanthemum flowers via HPLC/UV. Hortic. Environ. Biotechnol. 2024. [Google Scholar] [CrossRef]
  54. Doan, T.T.M.; Tran, G.H.; Nguyen, T.K.; Lim, J.H.; Lee, S. Antioxidant activity of different cultivars of Chrysanthemum morifolium and quantitative analysis of phenolic compounds by HPLC/UV. Appl. Biol. Chem. 2024, 67, 17. [Google Scholar] [CrossRef]
  55. So, J.; Lee, H.D.; Lee, S.; Lee, S.; Lim, J.H. Beneficial effects of the extracts and fractions of Dendranthema zawadskii and quantitative analysis of phenolic compounds by HPLC/UV. Chem. Pap. 2024. [Google Scholar] [CrossRef]
Figure 1. HPLC chromatogram of compounds 112: 3-O-Caffeoylquinic acid (1), schaftoside (2), isoschaftoside (3), luteolin 7-O-glucoside (4), apigenin 7-O-glucoside (5), 3,5-dicaffeoylquinic acid (6), 3,4-dicaffeoylquinic acid (7), 4,5-dicaffeoylquinic acid (8), acacetin 7-O-rutinoside (9), luteolin (10), apigenin (11), and acacetin (12).
Figure 1. HPLC chromatogram of compounds 112: 3-O-Caffeoylquinic acid (1), schaftoside (2), isoschaftoside (3), luteolin 7-O-glucoside (4), apigenin 7-O-glucoside (5), 3,5-dicaffeoylquinic acid (6), 3,4-dicaffeoylquinic acid (7), 4,5-dicaffeoylquinic acid (8), acacetin 7-O-rutinoside (9), luteolin (10), apigenin (11), and acacetin (12).
Pharmaceuticals 17 00340 g001
Figure 2. Representative HPLC chromatograms of extracts of the flowers of C. morifolium cultivars: (a) S3 and (b) S17. 3-O-Caffeoylquinic acid (1), luteolin 7-O-glucoside (4), apigenin 7-O-glucoside (5), 3,5-dicaffeoylquinic acid (6), 3,4-dicaffeoylquinic acid (7), 4,5-dicaffeoylquinic acid (8), acacetin 7-O-rutinoside (9), luteolin (10), apigenin (11), and acacetin (12).
Figure 2. Representative HPLC chromatograms of extracts of the flowers of C. morifolium cultivars: (a) S3 and (b) S17. 3-O-Caffeoylquinic acid (1), luteolin 7-O-glucoside (4), apigenin 7-O-glucoside (5), 3,5-dicaffeoylquinic acid (6), 3,4-dicaffeoylquinic acid (7), 4,5-dicaffeoylquinic acid (8), acacetin 7-O-rutinoside (9), luteolin (10), apigenin (11), and acacetin (12).
Pharmaceuticals 17 00340 g002
Figure 3. Representative HPLC chromatograms of extracts of the leaves of C. morifolium cultivars: (a) S24 and (b) S32. 3-O-Caffeoylquinic acid (1), schaftoside (2), isoschaftoside (3), luteolin 7-O-glucoside (4), apigenin 7-O-glucoside (5), 3,5-dicaffeoylquinic acid (6), 3,4-dicaffeoylquinic acid (7), 4,5-dicaffeoylquinic acid (8), acacetin 7-O-rutinoside (9), luteolin (10), apigenin (11), and acacetin (12).
Figure 3. Representative HPLC chromatograms of extracts of the leaves of C. morifolium cultivars: (a) S24 and (b) S32. 3-O-Caffeoylquinic acid (1), schaftoside (2), isoschaftoside (3), luteolin 7-O-glucoside (4), apigenin 7-O-glucoside (5), 3,5-dicaffeoylquinic acid (6), 3,4-dicaffeoylquinic acid (7), 4,5-dicaffeoylquinic acid (8), acacetin 7-O-rutinoside (9), luteolin (10), apigenin (11), and acacetin (12).
Pharmaceuticals 17 00340 g003
Figure 4. C. morifolium cultivars used in this study: (a) ‘Argus’, (b) ‘Young cream’, (c) ‘Powaru’, (d) ‘Fire Cream’, (e) ‘Argento’, (f) ‘Corsage’, (g) ‘Raina’, (h)’ Coral King’, (i) ‘White Cap’, (j) ‘Glorious Days’, (k) ‘Cutie Bubble’, (l) ‘Melina’, (m) ‘Cielo’, (n) ‘Shingeumsu’, (o) ‘Geumsu’, (p) ‘Yes Holic’, and (q) ‘Ford’.
Figure 4. C. morifolium cultivars used in this study: (a) ‘Argus’, (b) ‘Young cream’, (c) ‘Powaru’, (d) ‘Fire Cream’, (e) ‘Argento’, (f) ‘Corsage’, (g) ‘Raina’, (h)’ Coral King’, (i) ‘White Cap’, (j) ‘Glorious Days’, (k) ‘Cutie Bubble’, (l) ‘Melina’, (m) ‘Cielo’, (n) ‘Shingeumsu’, (o) ‘Geumsu’, (p) ‘Yes Holic’, and (q) ‘Ford’.
Pharmaceuticals 17 00340 g004
Figure 5. Chemical structures of 3-O-caffeoylquinic acid (1), schaftoside (2), isoschaftoside (3), luteolin 7-O-glucoside (4), apigenin 7-O-glucoside (5), 3,5-dicaffeoylquinic acid (6), 3,4-dicaffeoylquinic acid (7), 4,5-dicaffeoylquinic acid (8), acacetin 7-O-rutinoside (9), luteolin (10), apigenin (11), and acacetin (12).
Figure 5. Chemical structures of 3-O-caffeoylquinic acid (1), schaftoside (2), isoschaftoside (3), luteolin 7-O-glucoside (4), apigenin 7-O-glucoside (5), 3,5-dicaffeoylquinic acid (6), 3,4-dicaffeoylquinic acid (7), 4,5-dicaffeoylquinic acid (8), acacetin 7-O-rutinoside (9), luteolin (10), apigenin (11), and acacetin (12).
Pharmaceuticals 17 00340 g005
Table 1. DPPH and ABTS+ radical scavenging activities of extracts from the flowers of C. morifolium cultivars.
Table 1. DPPH and ABTS+ radical scavenging activities of extracts from the flowers of C. morifolium cultivars.
CultivarIC50 (mg/mL)
DPPHABTS+
‘Argus’ flower (S1)2.83 ± 0.132.64 ± 0.25
‘Young cream’ flower (S2)2.59 ± 0.152.40 ± 0.14
‘Powaru’ flower (S3)1.26 ± 0.081.14 ± 0.11
‘Fire Cream’ flower (S4)1.93 ± 0.192.02 ± 0.01
‘Argento’ flower (S5)2.68 ± 0132.94 ± 0.07
‘Corsage’ flower (S6)1.72 ± 0.141.77 ± 0.14
‘Raina’ flower (S7)1.35 ± 0.061.71 ± 0.05
‘Coral King’ flower (S8)1.99 ± 0.102.44 ± 0.32
‘White Cap’ flower (S9)2.53 ± 0.192.66 ± 0.29
‘Glorious Days’ flower (S10)2.64 ± 0.072.45 ± 0.36
‘Cutie Bubble’ flower (S11)1.45 ± 0.051.92 ± 0.06
‘Melina’ flower (S12)4.12 ± 0.394.49 ± 0.64
‘Cielo’ flower (S13)6.21 ± 0.475.65 ± 0.49
‘Shingeumsu’ flower (S14)2.61 ± 0.272.45 ± 0.29
‘Geumsu’ flower (S15)1.74 ± 0.061.33 ± 0.07
‘Yes Holic’ flower (S16)3.64 ± 0.133.16 ± 0.19
‘Ford’ flower (S17)1.27 ± 0.061.38 ± 0.09
Ascorbic acid0.10 ± 0.000.10 ± 0.00
Ascorbic acid was employed as the standard and as a reference.
Table 2. DPPH and ABTS+ radical scavenging activities of extracts from the leaves of C. morifolium cultivars.
Table 2. DPPH and ABTS+ radical scavenging activities of extracts from the leaves of C. morifolium cultivars.
CultivarIC50 (mg/mL)
DPPHABTS+
‘Argus’ leaf (S18)3.21 ± 0.183.17 ± 0.21
‘Young cream’ leaf (S19)6.45 ± 0.624.96 ± 0.19
‘Powaru’ leaf (S20)2.84 ± 0.242.95 ± 0.13
‘Fire Cream’ leaf (S21)3.32 ± 0.233.53 ± 0.04
‘Argento’ leaf (S22)4.74 ± 0.213.59 ± 0.07
‘Corsage’ leaf (S23)3.21 ± 0.192.46 ± 0.04
‘Raina’ leaf (S24)2.18 ± 0.191.85 ± 0.10
‘Coral King’ leaf (S25)5.32 ± 0.283.89 ± 0.11
‘White Cap’ leaf (S26)20.86 ± 0.9111.48 ± 0.26
‘Glorious Days’ leaf (S27)4.33 ± 0.263.66 ± 0.25
‘Cutie Bubble’ leaf (S28)7.15 ± 0.166.36 ± 0.05
‘Melina’ leaf (S29)17.25 ± 0.349.48 ± 0.37
‘Cielo’ leaf (S30)6.29 ± 0.386.29 ± 0.30
‘Shingeumsu’ leaf (S31)15.18 ± 0.728.24 ± 0.16
‘Geumsu’ leaf (S32)2.10 ± 0.091.82 ± 0.11
‘Yes Holic’ leaf (S33)3.40 ± 0.073.47 ± 0.07
‘Ford’ leaf (S34)2.65 ± 0.032.59 ± 0.11
Ascorbic acid0.10 ± 0.000.10 ± 0.00
Ascorbic acid was employed as the standard and as a reference.
Table 3. Calibration curves for compounds 112.
Table 3. Calibration curves for compounds 112.
CompoundtRCalibration EquationCorrelation Factor, r2
113.04Y = 6.5232X − 76.2650.9996
214.81Y = 10.639X − 26.4170.9996
315.54Y = 16.882X − 29.6280.9994
418.80Y = 19.962X − 97.2291.0000
523.26Y = 18.559X − 15.2591.0000
625.22Y = 7.9331X − 149.490.9998
727.86Y = 9.2577X − 65.5050.9992
828.84Y = 8.4014X − 173.620.9992
934.63Y = 9.2925X + 12.170.9998
1036.25Y = 25.5X − 93.2160.9997
1139.30Y = 46.97X + 47.1530.9997
1241.44Y = 21.014X + 41.3940.9999
3-O-Caffeoylquinic acid (1), schaftoside (2), isoschaftoside (3), luteolin 7-O-glucoside (4), apigenin 7-O-glucoside (5), 3,5-dicaffeoylquinic acid (6), 3,4-dicaffeoylquinic acid (7), 4,5-dicaffeoylquinic acid (8), acacetin 7-O-rutinoside (9), luteolin (10), apigenin (11), and acacetin (12). tR = retention time; Y = peak area; X = concentration of standards (µg/mL); r2 = correlation coefficient of five calibration data points (n = 3).
Table 4. Contents of compounds 112 in the flowers of C. morifolium cultivars.
Table 4. Contents of compounds 112 in the flowers of C. morifolium cultivars.
CultivarContent (mg/g Extract)
123456789101112Total
S13.08 ± 0.200.18 ± 0.01ND5.01 ± 0.275.84 ± 0.339.28 ± 0.451.64 ± 0.099.33 ± 0.57ND4.17 ± 0.082.20 ± 0.010.02 ± 0.0140.76
S25.95 ± 0.020.16 ± 0.00ND9.96 ± 0.122.10 ± 0.0113.38 ± 0.351.28 ± 0.0211.18 ± 0.20ND3.51 ± 0.010.09 ± 0.00ND47.62
S311.43 ± 0.43NDND34.22 ± 0.3724.23 ± 0.1623.00 ± 0.211.91 ± 0.0619.84 ± 0.440.25 ± 0.025.66 ± 0.020.12 ± 0.000.09 ± 0.00120.75
S47.68 ± 0.09NDND23.07 ± 0.4028.47 ± 0.2115.85 ± 1.062.34 ± 0.0815.12 ± 0.34ND5.80 ± 0.050.10 ± 0.010.08 ± 0.0198.51
S511.03 ± 0.37NDND9.31 ± 0.124.62 ± 0.0524.83 ± 0.844.86 ± 0.2121.65 ± 0.601.90 ± 0.011.09 ± 0.02trND79.29
S68.95 ± 0.21NDND17.48 ± 0.087.91 ± 0.0411.79 ± 0.342.07 ± 0.0113.05 ± 0.222.02 ± 0.07NDtr0.19 ± 0.0063.46
S719.39 ± 0.280.61 ± 0.00tr9.33 ± 0.0818.35 ± 0.0654.72 ± 1.094.58 ± 0.0640.31 ± 0.12ND0.44 ± 0.020.16 ± 0.001.93 ± 0.02149.82
S84.92 ± 0.17NDND25.56 ± 1.2122.95 ± 1.0412.28 ± 0.372.58 ± 0.0313.04 ± 0.311.00 ± 0.011.77 ± 0.100.69 ± 0.01ND84.78
S94.23 ± 0.040.34 ± 0.01ND13.15 ± 0.074.52 ± 0.025.36 ± 0.203.07 ± 0.1121.26 ± 0.165.65 ± 0.061.16 ± 0.020.21 ± 0.000.44 ± 0.0059.39
S105.45 ± 0.130.20 ± 0.01ND13.90 ± 0.118.44 ± 0.0611.43 ± 0.132.69 ± 0.0918.23 ± 0.19ND16.03 ± 0.181.68 ± 0.00tr78.04
S1111.69 ± 0.29NDND11.51 ± 0.1014.82 ± 0.0617.99 ± 0.285.62 ± 0.2351.05 ± 1.66ND0.62 ± 0.020.20 ± 0.020.56 ± 0.02114.05
S123.43 ± 0.030.29 ± 0.01ND5.33 ± 0.044.47 ± 0.023.31 ± 0.301.22 ± 0.036.13 ± 0.148.88 ± 0.07ND0.27 ± 0.001.05 ± 0.0234.39
S132.21 ± 0.030.23 ± 0.01tr9.26 ± 0.102.39 ± 0.042.60 ± 0.090.58 ± 0.022.41 ± 0.030.32 ± 0.025.69 ± 0.090.57 ± 0.010.07 ± 0.0126.32
S147.61 ± 0.14NDND6.28 ± 0.045.77 ± 0.038.75 ± 0.584.02 ± 0.1722.87 ± 0.235.40 ± 0.072.70 ± 0.010.14 ± 0.000.08 ± 0.0163.61
S156.67 ± 0.30NDND6.93 ± 0.135.72 ± 0.168.67 ± 0.522.07 ± 0.0523.95 ± 0.4114.15 ± 0.131.48 ± 0.110.32 ± 0.010.61 ± 0.0270.58
S164.14 ± 0.11NDND7.12 ± 0.141.20 ± 0.026.58 ± 0.131.90 ± 0.0910.45 ± 0.26ND2.92 ± 0.050.11 ± 0.010.15 ± 0.0134.57
S1720.07 ± 0.63NDND11.20 ± 0.043.33 ± 0.0582.93 ± 0.9611.08 ± 0.0761.06 ± 0.388.04 ± 0.152.07 ± 0.020.21 ± 0.000.69 ± 0.04200.68
tr = trace; ND = not detected.
Table 5. Contents of compounds 112 in the leaves of C. morifolium cultivars.
Table 5. Contents of compounds 112 in the leaves of C. morifolium cultivars.
CultivarContent (mg/g Extract)
123456789101112Total
S184.53 ± 0.050.30 ± 0.01tr0.93 ± 0.010.26 ± 0.0121.05 ± 0.262.05 ± 0.0210.71 ± 0.040.41 ± 0.010.34 ± 0.000.59 ± 0.00tr41.16
S192.56 ± 0.040.76 ± 0.01tr0.98 ± 0.010.21 ± 0.0011.92 ± 0.190.53 ± 0.004.45 ± 0.02ND1.88 ± 0.021.00 ± 0.010.35 ± 0.0024.66
S205.80 ± 0.25trND0.48 ± 0.000.22 ± 0.0019.78 ± 0.541.87 ± 0.039.74 ± 0.08ND0.77 ± 0.010.27 ± 0.00tr38.94
S214.25 ± 0.08trND0.47 ± 0.001.29 ± 0.0115.05 ± 0.201.15 ± 0.026.50 ± 0.110.28 ± 0.010.32 ± 0.00tr0.07 ± 0.0029.38
S221.57 ± 0.03trND0.32 ± 0.010.19 ± 0.017.88 ± 0.290.63 ± 0.013.38 ± 0.020.98 ± 0.02trtr0.43 ± 0.0115.38
S236.85 ± 0.270.68 ± 0.02tr0.34 ± 0.000.17 ± 0.0117.29 ± 0.360.69 ± 0.017.46 ± 0.110.67 ± 0.020.19 ± 0.01tr0.38 ± 0.0134.73
S247.44 ± 0.222.89 ± 0.060.51 ± 0.011.29 ± 0.010.42 ± 0.0030.57 ± 0.443.84 ± 0.0615.90 ± 0.29ND0.89 ± 0.010.18 ± 0.001.02 ± 0.0164.95
S251.37 ± 0.040.15 ± 0.00tr1.50 ± 0.010.34 ± 0.001.81 ± 0.020.70 ± 0.023.71 ± 0.020.41 ± 0.013.45 ± 0.020.54 ± 0.00tr13.98
S26tr0.60 ± 0.00tr0.39 ± 0.00trNDtr1.07 ± 0.013.16 ± 0.010.21 ± 0.00tr0.09 ± 0.005.52
S271.60 ± 0.010.53 ± 0.02tr0.90 ± 0.01tr2.27 ± 0.040.49 ± 0.014.08 ± 0.06ND0.46 ± 0.00tr0.09 ± 0.0010.42
S281.85 ± 0.020.15 ± 0.00ND0.42 ± 0.000.17 ± 0.001.10 ± 0.020.57 ± 0.013.55 ± 0.01ND0.19 ± 0.00tr0.24 ± 0.008.24
S29tr0.26 ± 0.01tr0.34 ± 0.01tr1.80 ± 0.06ND1.06 ± 0.002.95 ± 0.08NDND0.03 ± 0.006.44
S300.73 ± 0.020.34 ± 0.01tr0.58 ± 0.00tr1.03 ± 0.01ND1.54 ± 0.01ND0.32 ± 0.00tr0.20 ± 0.004.75
S310.76 ± 0.010.16 ± 0.01ND0.27 ± 0.00tr0.93 ± 0.03tr1.19 ± 0.002.39 ± 0.00trtrtr5.69
S323.29 ± 0.040.53 ± 0.01tr0.71 ± 0.010.33 ± 0.0128.23 ± 0.663.07 ± 0.0318.98 ± 0.1725.00 ± 0.280.59 ± 0.010.25 ± 0.010.76 ± 0.0281.73
S332.72 ± 0.010.16 ± 0.01ND0.70 ± 0.010.20 ± 0.014.83 ± 0.101.25 ± 0.027.02 ± 0.04tr1.23 ± 0.010.19 ± 0.000.75 ± 0.0019.04
S345.87 ± 0.291.55 ± 0.04tr0.78 ± 0.010.22 ± 0.005.86 ± 0.331.64 ± 0.1012.96 ± 0.196.43 ± 0.040.23 ± 0.00tr0.14 ± 0.0035.69
tr = trace; ND = not detected.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Doan, T.T.M.; Tran, G.H.; Nguyen, T.K.; Kang, K.S.; Lim, J.H.; Lee, S. Comparative Antioxidant Potentials and Quantitative Phenolic Compounds Profiles among the Flowers and Leaves from Various Chrysanthemum morifolium Cultivars. Pharmaceuticals 2024, 17, 340. https://doi.org/10.3390/ph17030340

AMA Style

Doan TTM, Tran GH, Nguyen TK, Kang KS, Lim JH, Lee S. Comparative Antioxidant Potentials and Quantitative Phenolic Compounds Profiles among the Flowers and Leaves from Various Chrysanthemum morifolium Cultivars. Pharmaceuticals. 2024; 17(3):340. https://doi.org/10.3390/ph17030340

Chicago/Turabian Style

Doan, Tham Thi Mong, Gia Han Tran, Toan Khac Nguyen, Ki Sung Kang, Jin Hee Lim, and Sanghyun Lee. 2024. "Comparative Antioxidant Potentials and Quantitative Phenolic Compounds Profiles among the Flowers and Leaves from Various Chrysanthemum morifolium Cultivars" Pharmaceuticals 17, no. 3: 340. https://doi.org/10.3390/ph17030340

APA Style

Doan, T. T. M., Tran, G. H., Nguyen, T. K., Kang, K. S., Lim, J. H., & Lee, S. (2024). Comparative Antioxidant Potentials and Quantitative Phenolic Compounds Profiles among the Flowers and Leaves from Various Chrysanthemum morifolium Cultivars. Pharmaceuticals, 17(3), 340. https://doi.org/10.3390/ph17030340

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop